• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

sarcoma - Articles and news items


FDA grants Priority Review for olaratumab BLA

Industry news / 4 May 2016 / Victoria White, Digital Content Producer

Lilly’s biologics license application is for olaratumab in combination with doxorubicin for the treatment of people with advanced soft tissue sarcoma…


Win an Amazon Gift Card worth up to €100!TAKE OUR SURVEY
+ +